Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neutropenia | D009503 | — | D70 | — | — | 3 | 1 | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 3 | — | 1 | 4 |
Chemotherapy-induced febrile neutropenia | D064146 | — | — | — | — | 2 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hematopoietic stem cell mobilization | D019650 | — | — | — | — | — | — | 1 | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | — | — | — | 1 | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | — | — | — | 1 | 1 |
Neoplasms | D009369 | — | C80 | — | — | — | — | 1 | 1 |
Lung neoplasms | D008175 | — | C34.90 | — | — | — | — | 1 | 1 |
Multiple myeloma | D009101 | — | C90.0 | — | — | — | — | 1 | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | — | — | — | — | 1 | 1 |
Fever | D005334 | — | R50.9 | — | — | — | — | 1 | 1 |
B-cell lymphoma | D016393 | — | — | — | — | — | — | 1 | 1 |
Febrile neutropenia | D064147 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Lenograstim |
INN | lenograstim |
Description | Lenograstim is a recombinant granulocyte colony-stimulating factor which functions as an immunostimulator. It is developed by Chugai Pharmaceuticals under the brand name Granocyte.
|
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109128 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6WS4C399GB (ChemIDplus, GSRS) |